HUMA

Humacyte (HUMA)

Humacyte Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HUMA

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/09	06 : 03	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HUMA	Humacyte Inc
2024/03/04	20 : 53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2024/03/01	06 : 11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HUMA	Humacyte Inc
2024/03/01	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2024/02/09	22 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/13	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/12/12	22 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2023/11/10	06 : 28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HUMA	Humacyte Inc
2023/11/10	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2023/10/11	05 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/10/11	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/09/16	05 : 09	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HUMA	Humacyte Inc
2023/09/16	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/09/16	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/09/12	20 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2023/09/12	09 : 03	Dow Jones News	Stocks to Watch: Oracle, Acelyrin, Humacyte	NASDAQ:HUMA	Humacyte Inc
2023/08/22	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/08/22	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/08/22	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
2023/08/18	05 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HUMA	Humacyte Inc
2023/08/14	21 : 44	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HUMA	Humacyte Inc
2023/08/14	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
2023/08/01	02 : 28	Dow Jones News	Humacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 Trial	NASDAQ:HUMA	Humacyte Inc
2023/07/26	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc